January 4, 2026
FDA’s first new motion sickness drug in decades may matter more for GLP-1 side effects
The FDA’s Dec. 30 approval of Vanda Pharmaceuticals’ Nereus (tradipitant) adds a rare new option to a category that has leaned for decades on older anticholinergics and antihistamines, including the scopolamine patch and over-the-counter products such as meclizine and dimenhydrinate. In reporting on the decision, Reuters noted the approval as the first new...January 4, 2026
Guthrie expands hospital president’s role
Sayre, Pa.-based Guthrie has appointed Jennifer Yartym as president of Guthrie Corning (N.Y.) Hospital, effective Jan. 1. Ms. Yartym will continue serving as president of Guthrie Cortland (N.Y.) Medical Center, a role she has held since 2019, according to a Jan. 2 health system LinkedIn post. She previously spent 19 years at Corning Hospital, including time as vice...January 4, 2026
The business case for ambulatory growth, despite lower pay
Health system C-suites across the U.S. are targeting ambulatory care expansion for 2026 as pressure mounts to lower cost of care and deliver on value-based promises. Even the nation’s largest health systems are strengthening their ambulatory footprints. Chicago-based CommonSpirit Health, which operates in 28 states, is focused on outpatient growth. “Our best...January 4, 2026
20,000 nurses at 12 New York City hospitals give strike notice
The New York State Nurses Association delivered 10-day strike notices Jan. 2 to 12 hospitals in New York City. Here are seven things to know: 1. If agreements are not reached, as many as 20,000 nurses could strike Jan. 12. This would mark the largest nurse strike in city history, according to a Jan. 2 union news release. 2. The notices followed the expiration of union...January 3, 2026
<![CDATA[JP Morgan 2026 Preview: What Path Will Pfizer Take?]]>
Continue reading →January 3, 2026
<![CDATA[Hoth Therapeutics Files Two Provisional Patent Applications to Expand Product Portfolio ]]>
Continue reading →January 3, 2026
<![CDATA[FDA Approves Nereus for the Prevention of Motion Induced Vomiting ]]>
Continue reading →January 3, 2026
McDonald’s rolls out global Happy Meal experience with Crayola
The item features space-themed activity kits and toys, as well as a digital element Continue reading →January 3, 2026
Noodles & Company receives delisting determination letter
The fast-casual restaurant chain appealed the delisting and has proposed a reverse stock split Continue reading →January 3, 2026
Starbucks partners with MrBeast to kick off the New Year
Starbucks is a sponsor for the YouTuber’s BeastGames and will launch a specialty drink as the pop culture collab trend continues Continue reading →January 3, 2026
Friday Squid Blogging: Squid Found in Light Fixture
Probably a college prank. As usual, you can also use this squid post to talk about the security stories in the news that I haven’t covered. Blog moderation policy. Continue reading →January 3, 2026




![<![CDATA[Hoth Therapeutics Files Two Provisional Patent Applications to Expand Product Portfolio ]]>](https://theindustryexpert.com/wp-content/uploads/2026/01/86c1d1a69215b5d64ec55097a79929f3c2e1f93f-1280x720-1-800x450.png)
![<![CDATA[FDA Approves Nereus for the Prevention of Motion Induced Vomiting ]]>](https://theindustryexpert.com/wp-content/uploads/2026/01/ab965ea0a889f2c2a2a31157d46dc13fdc90c31e-1280x720-1-800x450.png)



![<![CDATA[Five email security priorities every private practice should adopt in 2026]]>](https://theindustryexpert.com/wp-content/uploads/2026/01/19a7c1cd881c72267cb828e840447747922bf3f9-3600x2400-1-scaled-800x533.jpg)


